Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

    Recruiting

    2 1 1
    Denmark France Italy Spain
  • Study on Dabrafenib, Trametinib, and Imatinib for Patients with Rare and Hard-to-Treat Cancers

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Norway
  • Study on CD8 PET Imaging for Patients with Metastatic Solid Tumors Using 89Zr-Df-crefmirlimab, Nivolumab, and Cetrelimab

    Recruiting

    1 1 1 1
    Investigated Diseases:
    The Netherlands Spain
  • Study on the Diagnostic Performance of 68Ga-ABS011 PET/CT for Patients with Metastatic Breast Cancer

    Recruiting

    4 1 1
    Investigated Drugs:
    Austria Belgium
  • Study of ART6043, Olaparib, and Niraparib in Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Norway
  • Study on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors

    Recruiting

    3 1 1 1
    Czechia France Germany Greece Hungary Italy +4
  • Study of Lower Dose Olaparib Combined with Cobicistat to Improve Treatment Tolerance in Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on Atezolizumab, Amivantamab, and Futibatinib for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    France Germany Italy The Netherlands Spain Sweden
  • Study on Heart Function Changes in Cancer Patients Treated with Nivolumab or Pembrolizumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France